Hummingbird Diagnostics Announces Publication Evaluating miR-Blood's Small RNA Expression Dataset Capabilities in Nature’s Scientific Data
Hummingbird Diagnostics GmbH, a leader in using blood-based small RNAs for early disease detection and characterization, today announced a publication in Scientific Data, a peer-reviewed, open-access journal launched by Nature.
- Hummingbird Diagnostics GmbH, a leader in using blood-based small RNAs for early disease detection and characterization, today announced a publication in Scientific Data, a peer-reviewed, open-access journal launched by Nature.
- The study evaluated miR-Blood, Hummingbird Diagnostics’ small RNA expression dataset for eleven major components of human peripheral blood.
- A highly comprehensive blood cell type expression atlas for small RNAs, miR-Blood is capable of revealing highly cell-type specific patterns of small RNA expression, enabling a deeper understanding of blood and immune biology.
- This further supports Hummingbird’s approach of merging the analysis of tumor-derived and immune system-derived small RNA biomarkers,” remarked Dr. Rastislav Horos, Chief Technology Officer of Hummingbird Diagnostics.